Ampio Offers Update on Phase III Multicenter, Double-Blind STEP Study of Ampion
September 02, 2014 at 07:57 AM EDT
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™ ...